Pharmacovigilance (PV) is defined as the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem. WHO established its Programme for International Drug Monitoring in response to the thalidomide disaster detected in 1961. Together with the WHO Collaborating Centre for International Drug Monitoring, Uppsala, WHO promotes PV at the country level. At the end of 2010, 134 countries were part of the WHO PV Programme. The aims of PV are to enhance patient care and patient safety in relation to the use of medicines; and to support public health programmes by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines. 

According to the law of the Republic of Azerbaijan 1150-VQD dated May 18, 2018, in the country was introduced pharmacovigilance in order to regulate the activities of identifying, assessing, and preventing other undesirable consequences of using drugs.

Pharmacovigilance represents scientific research and activities aimed at identifying, evaluating, understanding, and prevention of possible adverse effects of medicines.

Pharmexpert company  provides full range of services in the field of pharmacovigilance from preparation of a single notification to full support in the field of PV, which includes:Qualified Person for Pharmacovigilance (QPPV)

National Persons Responsible for Pharmacovigilance (NPRP) in Azerbaijan Republic (also known as local QPPVs or LCP Local Contact Persons)

24 hours availability for pharmacovigilance

Development of standard operating procedures for pharmaceutical manufacturers, marketing authorisation holders,representatives of pharmaceutical companies

Development and implementation of safety measures

Development of documentation on pharmacovigilance

Continuous monitoring of the safety of drugs on the market

Communications with regulatory authorities

Communication with patients and other sources of information on adverse events

Monitoring and analysis of adverse events in clinical studies

Preparation of periodic notifications on cases of adverse events and reactions

Preparation of periodic safety update reports on of medicines

Collaboration with the quality assurance departments

Archiving of documentation

The cost of pharmacovigilance work depends on the scope of rendered services and is determined individually.

Open chat
1
Hello.For contact right now,,please,push the icon below.
Здравствуйте.Для контакта прямо сейчас,нажмите,пожалуйста,иконку ниже.
Powered by